chocardiographically determined left ventricular (LV) mass is a potent independent predictor of cardiovascular morbidity and mortality in essential hypertension (EHT) 1,2 and furthermore, there is increasing evidence of a link between hyperinsulinemia and cardiovascular risk. 3 Insulin may exert a direct growth-promoting effect on cardiac myocytes and could be involved in the pathogenesis of EHT. 4 Not only insulin, but insulin-like growth factor-1 (IGF-1) is also important in the hypertrophic response of cardiac myocytes, by binding to the IGF-1 receptors because of its structural similarity to insulin. 4, 5 In the clinical setting, an inverse association is reported between insulin sensitivity and left ventricular wall thickness in EHT. 6 It is well established that cardiac myocyte hypertrophy and disarray, increased interstitial collagen synthesis and medial thickening in the intramural coronary arteries are the clinical and pathological manifestations of hypertrophic cardiomyopathy (HCM). However, the factors that account for the variability in the phenotypic expression of the disorder remain largely unknown. According to the hypothesis of Marian, increased expression of trophic and mitotic factors such as IGF-1, transforming growth factor 1 and angiotensin II is a major contributor to the pathological manifestations of HCM. 7 In fact, several reports have shown that the expression of both the mRNA and protein for IGF-1 are elevated in HCM cardiac myocytes. 8, 9 In addition, Saeki et al showed that the level of circulating IGF-1 is related to the clinical condition of HCM, particularly congestive heart failure associated with HCM. 10 However, despite its structural similarity to IGF-1, pathological role of insulin in HCM is still incompletely known.
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Accordingly, the present study was undertaken to examine whether hyperinsulinemia caused by insulin resistance is present in HCM and whether insulin resistance (IR) is related to clinical manifestations of HCM.
Methods

Study Population
We enrolled 55 nondiabetic patients with HCM (46 men, 9 women; mean age: 57±10 years), 35 nondiabetic patients with EHT (20 men, 15 women; mean age: 56±9 years) and 15 normotensive control subjects (NC) (10 men, 5 women; mean age: 53±15 years) after they gave informed consent. They had normal findings on chemical screening battery and were nondiabetic by the criteria of the American Diabetes Association. 11 All of them underwent a coronary angiographic study and none had coronary artery disease. The study was carried out in accordance with the Declaration of Helsinki (1989) of the World Medical Association.
HCM was defined as the presence of a hypertrophied, nondilated ventricle in the absence of underlying cardiac or systemic secondary causes and was based on the World Health Organization/International Society and Federation of Cardiology definition of cardiomyopathies. 12 Patients with HCM were subdivided into 2 groups: hypertrophic obstructive cardiomyopathy (HOCM) and hypertrophic nonobstructive cardiomyopathy (HNCM). HOCM was diagnosed when a patient had a left ventricular pressure gradient (LVPG) greater than 30mmHg without provocation in the left ventricular outflow tract and/or midventricle. 13 Thirty-eight (69%) patients had been taking -blockers and 42 patients (76%) had been taking calcium antagonists after the evaluation of IR.
In never treated and nondiabetic hypertensive patients, a complete medical history and physical examination and appropriate laboratory evaluation failed to reveal a secondary cause for the hypertension. 14 Blood pressure was measured in triplicate by a single physician who was expert in the evaluation of hypertension, with an appropriate arm cuff and a mercury sphygmomanometer after a 5-min rest while seated. The arithmetic mean of the last 2 measurements was calculated. Korotkoff phase V was taken for diastolic blood pressure. Hypertension was defined as systolic blood pressure equal to or greater than 140 mmHg and/or diastolic blood pressure equal to or greater than 90 mmHg. 15 
Assessment of Insulin Resistance
After an overnight fast, a venous blood sample was taken from each subject in the morning in the outpatient clinic. Plasma glucose was immediately determined by the glucose oxidase method, and plasma insulin was determined in duplicate by highly specific and sensitive immunoradiometric assay (Abbott, Japan; intra-assay coefficient of variation (CV) 1.6%, interassay CV 2.2%).
Insulin resistance was assessed from the values for fasting immunoreactive insulin (FIRI) and fasting plasma glucose (FPG) and the previously validated homeostasis model assessment (HOMA-IR); 16 thus, HOMA-IR = FIRI ( U/ml) × FPG (mmol/L)/22.5. Low HOMA-IR values mean normal insulin sensitivity and high values mean the presence of resistance. The upper limit of HOMA-IR of juveniles is reported as 1.0. 16 
Echocardiography
Two-dimensionally guided M-mode echocardiography was performed by standard methods, as previously described, 14, 17 using an SSD-870 or SSD-5500 echocardiograph with a 3.5 MHz transducer (Aloka Inc, Tokyo, Japan). LV internal dimension (LVID), interventricular septal thickness (IVST) and left ventricular posterior wall thickness (LVPWT) were measured at end-diastole and end-systole, according to the American Society of Echocardiography guidelines, 18 and used for all purposes except determination of left ventricular mass (LVM, which was calculated at end-diastole using the Penn convention. 19 The LVM index was measured as follows: LVMI = LVM/body 
Subgroups Analysis
Patients with HCM were distributed into the following 2 balanced subgroups: HOCM group (LVPG ≥30 mmHg) (n=20) and HNCM group (LVPG <30 mmHg) (n=35) ( Table 1) . On the basis of IR, patients with HCM were then subdivided into 2 different groups by median HOMA-IR value (Table 2) : HOMA-IR ≥2.6 and HOMA-IR <2.6.
To evaluate whether the abnormality of IR is related to the prognosis and cardiovascular events in patients with HCM, the following events were prospectively confirmed. Total deaths, including sudden cardiac death, congestive heart failure and cancers, and congestive heart failure as a cardiovascular event were checked. Congestive heart failure was defined as the clinical symptoms were New York Heart Association Functional Class III or IV and lung congestion associated with left heart failure was confirmed on chest X-ray.
Statistical Analysis
All values are expressed as mean ± SD. One-way analysis of variance (ANOVA) was used to evaluate difference among groups, with Scheffe's correction for multiple comparisons. Two tailed unpaired Student's t-test was used to compare study the response of variables between categories. Categorical variables were compared with Fisher's exact and chi-square tests. Correlation coefficients were calculated according to Pearson's method. A multiple regression analysis was also performed to select appropriate independent variables producing the highest partial correlation with HOMA-IR in HCM group. Probability values less than 0.05 were considered statistically significant in all analyses.
Results
Baseline Characteristics
The biochemical and hemodynamic characteristics of the 3 groups are shown in Table 3 . There were no significant differences in age, sex distribution or body mass index (BMI) among the 3 groups. FPG in the HCM or EHT group was significantly higher than that in the NC; however, there was no significant difference in FPG between the HCM and EHT groups. FIRI in the HCM or EHT group was significantly higher than that in the NC group and FIRI was significantly higher in the HCM group than in the EHT group. Office blood pressure in the EHT group was significantly higher than that in either the HCM or NC group. There was no significant difference in office blood pressure between the HCM and NC groups. IVST was largest in the HCM group, followed by that in the EHT group and then the NC group. PWT in both the HCM and EHT groups was larger than that in the NC group, but there was no significant difference in PWT between the HCM and EHT groups.
The biochemical and hemodynamic characteristics of the HOCM and HNCM groups are shown in Table 1 . There were no significant differences in age, sex distribution, BMI or office blood pressure. FIRI in the HOCM group was significantly higher than that in the HNCM group, but there was no significant difference in FPG between 2 the groups. IVST was larger in the HOCM than in the HNCM group, but there was no significant difference between them in LVPWT. Fig 1 shows in the EHT group. In addition, the HOMA-IR values in the HOCM group were significantly higher than those in the HNCM group (Table 1) . There were no significant differences in sex distribution, office blood pressure, IVST and LVPWT between patients with HCM having high HOMA-IR values and those with low HOMA-IR values. However, HCM patients with high HOMA-IR values were significantly younger than those with low HOMA-IR values ( Table 2) .
Determinants of IR
As indicated in Fig 2, the HOMA-IR values showed a significant association with the LVPG in the HCM group. Table 4 shows the results of multiple regression analysis: independent determinants of the HOMA-IR values were LVPG, IVST and BMI in the HCM group. Age and systolic blood pressure did not achieve enough significance to enter the model.
Follow-up Results
Table 2 also shows the prognosis in patients with HCM during a mean follow-up of 105±50 months. Of these, 18 (64%) patients taking -blockers and the 22 (79%) taking calcium antagonists had high HOMA-IR values compared with 20 (74%) and 20 (74%), respectively, who had low HOMA-IR values. There were no significant differences in medical treatment between the 2 HCM groups. The incidence of sudden cardiac death was significantly higher in patients with HCM and high HOMA-IR values than in patients with HCM and low HOMA-IR values. The HOMA-IR values in 4 patients with HCM who died suddenly were 2.73, 2.93, 3.29 and 4.79, respectively. There was, however, no significant difference in the incidence of congestive heart failure between the 2 HCM groups.
Discussion
The present study documents for the first time that patients with HCM without apparent diabetes mellitus or hypertension have IR. The LVPG without provocation, IVST and BMI were powerful independent determinants of IR in patients with HCM. HCM is a primary disease of the myocardium that is diagnosed by the presence of left ventricular hypertrophy without increased external load and a small left ventricular cavity. However, the results of our present study strongly suggest that HCM is also a systemic disease that involves systemic skeletal muscles and vascular endothelial cells.
Effects of Insulin on Left Ventricular Hypertrophy
It is well established that peripheral hyperinsulinemia in patients with hypertension is a marker of IR. 6, 22 Diminished insulin sensitivity with regard to glucose utilization causes a substantial increase of insulin production in an attempt to maintain normal glucose utilization, making it possible that cardiovascular trophic effects and other actions of insulin are exaggerated. We calculated the HOMA-IR values to obtain a better quantitative estimate of IR 23 and in the present study, we showed a significant association between the echocardiographically determined LVMI and the HOMA-IR values in hypertensive patients, thereby confirming previous positive reports. Furthermore, Paternostro et al have reported that IR is a feature of the hypertrophied heart even in the absence of hypertension, coronary artery disease and diabetes mellitus. 24 The direct effect of insulin on cardiac myocyte growth could be mediated at least in part, by the IGF-1 receptors, 25 but unfortunately, we could not determine the IGF-1 binding protein in the present study. However, because the HOMA-IR values reflect fasting insulin levels, our data suggest that insulin is powerful determinant of LVM in subjects with untreated EHT and normal glucose tolerance. In addition, hypertensive patients with glucose intolerance have more severe left ventricular hypertrophy and left ventricular diastolic dysfunction than those with normal glucose tolerance. 26 
Hyperinsulinemia Caused by IR in HCM
Verdecchia et al reported that insulin and IGF-1 were powerful independent determinants of LVM in nondiabetic patients with hypertension. 27 On the other hand, Marian reported the possibility that IGF-1 was up-regulated in patients with HCM because of decreased cardiac contractility, resulting in the pathologic manifestations of HCM. 7 Despite its structural similarity to IGF-1, the relationship between insulin and HCM, which is another cause of left ventricular hypertrophy and diastolic dysfunction, is incompletely understood. The present study disclosed that the LVPG without provocation, IVST and BMI are important determinants of IR, and that these relations are independent of age, sex distribution and office blood pressure in patients with HCM. In hypertensive patients, it has been reported that IR plays an important role in the initiation and development of hypertension, 28 but insulin may not play a major independent role in the elevation of blood pressure in patients with HCM.
Almost half of the cases of HCM are reported to have autosomal-dominant type family history of this disease. At the present time, the gene abnormalities reported in patients with HCM are mainly those of the sarcomere components of the myocyte. Although the mechanism of myocardial hypertrophy in these patients is not fully understood, increased Ca 2+ sensitivity has been reported in various types of mutations. 29, 30 In addition, calcineurin, a Ca 2+ /calmodulindependent phosphatase, is reported to play an important role in the development of cardiac hypertrophy. 31 Insulin activates insulin receptor substrate-1 (IRS-1) by tyrosine phosphorylation and then phosphatidylinositol 3-kinase within the cytoplasm, resulting in various insulin actions such as enhancing glucose uptake and glycogen synthesis. Recently, Hallak et al reported that dephosphorylation of IRS-1 was calcium dependent and inhibited by the calcineurin inhibitor, cyclosporin, in primary cultured rat cerebellar granule neurons, suggesting the importance of calcineurin in the regulation of IRS-1 tyrosine phosphorylation. 32 Naya et al reported that calcineurin activation induced slow muscle fiber gene expression of skeletal muscles in transgenic mice. 33 In fact, microscopic examinations of biopsy specimens of the soleus muscle from patients with HCM caused by -myosin mutations have demonstrated a skeletal myopathy similar to central core disease, characterized by a predominance of type I slow fibers and absence of mitochondria in the center of many type I fibers. 34 Musaro et al 35 and Semsarian et al 36 also reported that calcineurin and transcription factor NF-ATc1 mediated the hypertrophic effects of IGF-1 in skeletal muscles. How insulin sensitivity is diminished in patients with HCM remains unknown. However, in the light of these reports, it is possible that increased systemic calcineurin activity in patients with HCM suppresses the intracellular signal transduction of insulin receptors in the skeletal muscles, which results in IR.
Relationship Between IR and Prognosis in HCM
The natural history of HCM is not yet fully understood. In the clinical setting, we sometimes encounter sudden cardiac death and congestive heart failure in patients with HCM. Four of the present HCM patients died suddenly during the follow-up period and all of them had high HOMA-IR values. The multiple regression analyses determined that LVPG was the most powerful independent determinant of the HOMA-IR values in HCM. In addition, there is only a suggested association but neither clinical relevance nor independent linkage between sudden cardiac death and left ventricular outflow obstruction. 37 Therefore, our findings regarding the association between IR and sudden cardiac death in patients with HCM may be mediated through the LVPG without provocation.
On the other hand, Hecht et al indicated that end-stage heart failure, characterized by left ventricular enlargement, wall thinning and decreased wall motion, was an important cause for death, especially in older patients with familial HCM. 38 In addition, heart failure was associated with IR in dilated cardiomyopathy. 39 Of the present patients with HCM, 9 had congestive heart failure during the follow-up period, but there was no significant association between the incidence of heart failure and IR. Unfortunately, we could not assess the follow-up data regarding left ventricular size, wall thickness and wall motion.
Conclusions
We have shown that patients with HCM without apparent diabetes mellitus and hypertension have significant IR in comparison with hypertensive patients or normotensive control subjects. Our findings also suggest that IR may be related to sudden cardiac death mediated through the LVPG in patients with HCM. Further more extensive and long-term follow-up studies of large number of patients with HCM are needed to evaluate the exact mechanisms by which patients with HCM develop IR and the association between IR and the clinical manifestations of HCM.
